We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+4.41%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$6.04B
AUM Growth
+$73M
(+1.2%)
Cap. Flow
-$144M
Cap. Flow
% of AUM
-2.38%
Top 10 Holdings %
Top 10 Hldgs %
13.22%
Holding
1,047
New
173
Increased
233
Reduced
390
Closed
225
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$50M |
| 2 |
Merck
MRK
|
+$46.7M |
| 3 |
Cognizant
CTSH
|
+$37.2M |
| 4 |
Las Vegas Sands
LVS
|
+$25.6M |
| 5 |
PARA
Paramount Global Class B
PARA
|
+$25M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DTV
DIRECTV COM STK (DE)
DTV
|
+$51.6M |
| 2 |
Comcast
CMCSA
|
+$48.7M |
| 3 |
Intel
INTC
|
+$38.4M |
| 4 |
Amazon
AMZN
|
+$38.4M |
| 5 |
FRX
FOREST LABORATORIES INC
FRX
|
+$36.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.81% |
| 2 | Industrials | 13.63% |
| 3 | Financials | 13.56% |
| 4 | Healthcare | 12.66% |
| 5 | Consumer Discretionary | 11.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
101
Intel
INTC
$504B
| $19.3M | 0.32% |
623,260
-1,401,180
| -69% | -$38.4M |
|
102
Alphabet (Google) Class C
GOOG
$3.88T
| $19.2M | 0.32% |
667,849
-97,288
| -13% | -$2.64M |
|
|
SCHW
103
Charles Schwab
SCHW
$177B
| $18.9M | 0.31% |
+702,020
| New | +$18.4M |
|
104
Procter & Gamble
PG
$342B
| $18.6M | 0.31% |
237,278
-2,700
| -1% | -$218K |
|
|
AHL
105
DELISTED
ASPEN Insurance Holding Limited
AHL
| $18.6M | 0.31% |
408,709
-2,850
| -0.7% | -$128K |
|
106
Patterson-UTI
PTEN
$3.93B
| $18.5M | 0.31% |
528,069
+256,819
| +95% | +$8.43M |
|
107
Hershey
HSY
$34.9B
| $18.1M | 0.3% |
186,371
-420
| -0.2% | -$41.2K |
|
108
Cardinal Health
CAH
$52.9B
| $18M | 0.3% |
262,284
+95,924
| +58% | +$6.53M |
|
109
PTC
PTC
$13.1B
| $17.9M | 0.3% |
460,363
-26,339
| -5% | -$949K |
|
110
ON Semiconductor
ON
$35.1B
| $17.6M | 0.29% |
1,927,923
+640,200
| +50% | +$5.83M |
|
111
HCA Healthcare
HCA
$83.5B
| $17.5M | 0.29% |
311,190
+41,330
| +15% | +$2.18M |
|
112
Boston Scientific
BSX
$64.8B
| $17.5M | 0.29% |
+1,368,128
| New | +$17.8M |
|
113
Principal Financial Group
PFG
$23.2B
| $17.4M | 0.29% |
343,740
+138,870
| +68% | +$6.54M |
|
114
Autodesk
ADSK
$43.3B
| $17.3M | 0.29% |
307,300
+225,660
| +276% | +$11.4M |
|
|
CMA
115
DELISTED
Comerica
CMA
| $17.3M | 0.29% |
344,180
+50,570
| +17% | +$2.47M |
|
|
PRE
116
DELISTED
PARTNERRE LTD
PRE
| $16.9M | 0.28% |
154,351
-24,896
| -14% | -$2.63M |
|
|
117
Amazon
AMZN
$2.51T
| $16.8M | 0.28% |
1,034,220
-2,424,600
| -70% | -$38.4M |
|
118
Travelers Companies
TRV
$78.5B
| $16.7M | 0.28% |
177,520
-16,620
| -9% | -$1.52M |
|
119
ServiceNow
NOW
$94.8B
| $16.5M | 0.27% |
1,335,300
-890,305
| -40% | -$9.51M |
|
|
BIG
120
DELISTED
Big Lots, Inc.
BIG
| $16.5M | 0.27% |
360,474
+330,024
| +1,084% | +$13.4M |
|
|
IM
121
DELISTED
Ingram Micro
IM
| $16.4M | 0.27% |
562,520
+469,040
| +502% | +$13.2M |
|
|
DD
122
DELISTED
Du Pont De Nemours E I
DD
| $16.4M | 0.27% |
+263,913
| New | +$17M |
|
|
BHI
123
DELISTED
Baker Hughes
BHI
| $16.4M | 0.27% |
219,870
+194,250
| +758% | +$13.5M |
|
124
VF Corp
VFC
$6.49B
| $16.2M | 0.27% |
273,249
+23,095
| +9% | +$1.34M |
|
125
Humana
HUM
$47.4B
| $16.1M | 0.27% |
125,840
-12,960
| -9% | -$1.53M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2014 Portfolio in Review
As of Q2 2014, Jacobs Levy Equity Management held 1,047 positions worth $6.04B, up 1.2% from $5.97B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jacobs Levy Equity Management's Q2 2014 filing shows 173 new, 233 increased, 390 reduced and 225 closed positions. Its largest new stake was Merck: 856,750 shares worth $47.3M. The largest sale was DIRECTV COM STK (DE), an estimated $51.6M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Industrials and Financials.
- Jacobs Levy Equity Management's largest Q2 2014 buy was Merck: 856,750 shares worth $47.3M.
- Jacobs Levy Equity Management added most to Pfizer in Q2 2014, an estimated $50M increase.
- Jacobs Levy Equity Management's biggest Q2 2014 reduction was Comcast, cutting an estimated $48.7M.
- Jacobs Levy Equity Management fully exited DIRECTV COM STK (DE) in Q2 2014, selling an estimated $51.6M.
- Jacobs Levy Equity Management's ten largest holdings make up 13% of its $6.04B portfolio in Q2 2014.
- Jacobs Levy Equity Management opened 173 new positions and closed 225 in Q2 2014.
- Jacobs Levy Equity Management's portfolio value rose 1.2% quarter-over-quarter to $6.04B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2014, filed 14 Aug 2014.